Evidence map›Paper›PMID 41356968›Full record

ArticleCureus2025

Whole-Body Dose of Patients Treated With ZAP-X Intracranial Gyroscopic Stereotactic Radiosurgery.

Georg A Weidlich

Erratum issuedAbstract read
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author.

Georg A WeidlichMedical Physics, ZAP Surgical Systems, San Carlos, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

During the delivery of radiosurgery treatments, a small dose is given unintentionally to the areas of the patient's body outside the primary treatment volume. It is a common practice for radiotherapy platform developers to minimize the dose outside the primary radiation field by providing X-ray target shielding in the beam-defining collimator head of such systems. The amount of such doses was measured for the ZAP-X

Indexed as

in vivophoton stereotactic radiosurgeryunintended dosewhole-body dosezap-x® radiosurgery

Identifiers

PMID41356968
PMCPMC12677837

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.